Organigram Global (OGI) Cash from Investing Activities (2018 - 2026)

Organigram Global (OGI) posted quarterly Cash from Investing Activities of -$4.2 million for Q1 2026, up 41.53% year-on-year from -$3.0 million in Q1 2025, and down 34.72% on a QoQ basis from -$3.1 million in Q4 2025.

Organigram Global (OGI) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Cash from Investing Activities for 7 consecutive years, with -$4.2 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash from Investing Activities rose 41.53% year-over-year to -$4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$58.6 million (up 65.75% YoY) and the FY2025 annual result came in at -$58.9 million, down 160.87% from the prior year.
  • Cash from Investing Activities retreated to -$4.2 million in Q1 2026 per OGI's latest filing, from -$3.1 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for OGI reached as high as -$3.1 million in Q4 2025 and fell as low as -$44.1 million in Q4 2024.
  • A 3-year average of -$14.6 million and a median of -$5.7 million in 2025 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2025 — Cash from Investing Activities soared 92.93% — and 2026, when it soared 41.53%.
  • Year by year, Cash from Investing Activities stood at -$44.1 million in 2024, then surged by 92.93% to -$3.1 million in 2025, then tumbled by 34.72% to -$4.2 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$4.2 million, -$3.1 million, and -$7.2 million for Q1 2026, Q4 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.95 Bn 88.09 Bn - -
2 Teva Pharmaceutical Industries 35.88 Bn 32.14 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.64 Bn 30.70 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.04 Bn 20.88 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.37 Bn 18.57 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.45 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.65 Bn 12.22 Bn 785.00 Mn -60.00 Mn
10 Organigram Global 120.15 Mn 153.23 Mn 28.97 Mn -4.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.20 Mn
Mar 31, 2026 -4.20 Mn
Dec 31, 2025 -3.12 Mn
Dec 31, 2025 -3.12 Mn
Mar 31, 2025 -7.18 Mn
Mar 31, 2025 -7.18 Mn
Dec 31, 2024 -44.06 Mn
Dec 31, 2024 -44.06 Mn
May 31, 2021 -153.91 Mn
May 31, 2021 -153.91 Mn
Feb 28, 2021 34.18 Mn
Feb 28, 2021 34.18 Mn
Nov 30, 2020 15.81 Mn
Nov 30, 2020 15.81 Mn
Aug 31, 2020 -177.81 Mn
Aug 31, 2020 -177.81 Mn
May 31, 2020 32.68 Bn
May 31, 2020 32.68 Bn
Feb 29, 2020 68,052.00
Feb 29, 2020 68,052.00